KTTA
Pasithea Therapeutics Corp
NASDAQ: KTTA · HEALTHCARE · BIOTECHNOLOGY
$0.69
+0.87% today
Updated 2026-04-30
Market cap
$17.21M
P/E ratio
—
P/S ratio
42.15x
EPS (TTM)
$-2.91
Dividend yield
—
52W range
$0 – $2
Volume
0.4M
Pasithea Therapeutics Corp (KTTA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-58.40%
ROA
-27.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | — | $-61476.00 | — | — | — |
| 2021 | $15062.00 | $-2.17M | -14.69% | -29,925.73% | -14,430.49% |
| 2022 | $486559.00 | $-13.94M | -1.05% | -2,587.35% | -2,864.29% |
| 2023 | $486559.00 | $-15.96M | -133.27% | -3,284.16% | -3,280.52% |
| 2024 | $0.00 | $-13.90M | — | — | — |
| 2025 | $0.00 | $-20.43M | — | — | — |